ESC Premium Access

The five-beat averaged method of assessing aortic stenosis in atrial fibrillation significantly underestimates stenosis severity compared to sinus rhythm.

Presentation

About the speaker

Doctor Stephen Tomlinson

The Prince Charles Hospital, Brisbane (Australia)
0 follower

8 more presentations in this session

One-year echocardiographic outcomes of transcatheter aortic valve implantation with or without predilatation of the aortic valve: Insights from the multicenter, randomized DIRECT trial.

Speaker: Doctor M. Karmpalioti (Athens, GR)

Thumbnail

Prognosis and clinical outcomes after TAVI, regarding the extravalvular cardiac damage defined by echocardiography prior the procedural.

Speaker: Doctor J. Borrego Rodriguez (Leon, ES)

Thumbnail

Flow rate and stroke volume index as predictors of mortality in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor S. Abdelrazek (Bad Krozingen, DE)

Thumbnail

Prognostic relevance of exercise pulmonary hypertension for new-onset atrial fibrillation in primary mitral regurgitation

Speaker: Doctor K. Teramoto (Kawasaki, JP)

Thumbnail

Ischaemic mitral regurgitation: incidence, clinical and angiographic characteristics of 1000 patients with type 1 myocardial infarction undergoing percutaneous coronary intervention

Speaker: Doctor H. Sharma (Birmingham, GB)

Thumbnail

Access the full session

Echocardiography in Valvular Heart Disease: New Insights

Speakers: Doctor S. Tomlinson, Doctor M. Karmpalioti, Doctor J. Borrego Rodriguez, Doctor S. Abdelrazek, Doctor K. Teramoto...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

Preventing sudden death: alternatives to transvenous defibrillators - Chat Moderator.

27 August 2021

ESC Premium Access

Sudden cardiac death: can we move from prediction to prevention? - Chat Moderator.

27 August 2021

Open Access

Round table discussion with audience Q&A, Summary and close.

27 August 2021

This platform is supported by

logo Novo Nordisk